Sanofi's new facility builds on the company's expansive footprint in Ontario, which includes a full spectrum of R&D, manufacturing, clinical trials, regulatory, distribution and commercial operations. As part of Sanofi's 2,000 employees in Canada, the facility will employ 200 people and is supported by federal, municipal and provincial governments, including a $50-million investment from the Province of Ontario. Sanofi is also building a second new facility at its Toronto campus to increase production of the Fluzone High-Dose Influenza Vaccine, a flu vaccine specifically formulated for people 65 years and older. CGC Inc., the Canadian division of USG Corporation, announced construction has started on its new manufacturing plant in Wheatland County in south-central Alberta. CGC is investing $210 million to build the facility, designed to be the most eco-friendly plant the company has ever constructed.